In the BioHarmony Drug Report Database
Posaconazole
Noxafil (posaconazole) is a small molecule pharmaceutical. Posaconazole was first approved as Noxafil on 2005-10-25. It is used to treat mycoses and oral candidiasis in the USA. It has been approved in Europe to treat aspergillosis, candidiasis, coccidioidomycosis, and mycoses. Noxafil’s patents are valid until 2033-02-27 (FDA).
Trade Name
|
Noxafil |
|---|---|
Common Name
|
posaconazole |
ChEMBL ID
|
CHEMBL1397 |
Indication
|
aspergillosis, candidiasis, coccidioidomycosis, mycoses, oral candidiasis |
Drug Class
|
Systemic antifungals (miconazole type) |
Image (chem structure or protein)